Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.001 per share, of Adamas Pharmaceuticals, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments to such joint filing and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others.

Dated: November 1, 2017
	Kerrisdale Partners Master Fund Ltd
	Signature:	/s/ Sahm Adrangi
	Name: Sahm Adrangi
	Title: Director
	Kerrisdale Advisers, LLC
	Signature:	/s/ Sahm Adrangi
	Name: Sahm Adrangi
	Title: Managing Member
	/s/ Sahm Adrangi
	Sahm Adrangi